RAD51 Inhibitor and Radiation Toxicity in Vestibular Schwannoma is a research paper published in Otolaryngology (2022). On theSindex it has a DataRank of 0.241. It has been cited 4 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.241
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Institutes of Health
Grant: K08DC017508
National Institutes of Health
Grant: R01DC017264‐01
NCI NIH HHS
Grant: R01 CA187053
NIDCD NIH HHS
Grant: R01 DC017264
NIDCD NIH HHS
Grant: T32 DC015995
NIDCD NIH HHS
Grant: L30 DC018981
National Institutes of Health
Grant: 5K08DC017508-05
Tumor-Mediated Hearing Loss in Neurofibromatosis Type II
National Institutes of Health
Grant: 5R01DC017264-03
Preclinical Testing of PI3K Inhibitors for Vestibular Schwannomas
National Cancer Institute
National Institute on Deafness and Other Communication Disorders
National Institutes of Health
FWCI
0.59
Citation Percentile
0.6%
Influential Citations
1
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals